Loading
Latest filing published 20 Jul 2026 for Swedish Orphan Biovitrum AB (publ), €632k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lena Bjurner is a declared insider of Swedish Orphan Biovitrum AB (publ), with filings sourced from Finansinspektionen. In total, 5 filings cover trades dated from 12 June 2026 to 20 July 2026.
On the open market, the record shows 2 purchases worth €1.3M and 2 sales worth €1.4M. Sales outweigh purchases by €164k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
Most recently, on 20 July 2026, the filings show an open-market purchase worth €632k in Swedish Orphan Biovitrum AB (publ). The median gap between a trade and its publication by Finansinspektionen is 3 days. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations